Volume 9 Supplement 2

Annual Conference on Hereditary Cancers 2009

Open Access

Allel RET+3 : T a medullary thyroid cancer

  • A Pławski1 and
  • M Podralska1
Hereditary Cancer in Clinical Practice20119(Suppl 2):A12

https://doi.org/10.1186/1897-4287-9-S2-A12

Published: 1 June 2011

In our studies, we compared the frequency of the occurrence of the RET+3 : T allele in our group of 48 medullary thyroid cancer (MTC)patients with the frequency of occurrence of the allele in the Polish population. The frequency of the occurrence of the heterozygote variant of the RET+3 : T for the Polish population reached almost 12% (18/152) of heterozygotes, but in the group of patients with MTC, we did not find even a single RET+3 : T allele. The frequency difference is statistically significant and in the Fisher's Exact Test, the two-sided P value is 0.0080. This observation allows assuming that the occurrence of the RET+3 : T in the heterozygotic state may lead to the inhibition of the disease phenotype in the cases of the medullary thyroid carcinoma.

Authors’ Affiliations

(1)
Institute of Human Genetics, Polish Academy of Sciences

Copyright

© Pławski and Podralska; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement